Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001897612-26-000700·T. Rowe Price Investment Management, Inc.
Schedule 13G ownership disclosure
Vaxcyte Inc
COMMON STOCK · CUSIP: 92243G108
Event date: 2026-09-30
- Filing-level shares
- 14,312,368
- Percent of class
- 9.6%
- T. Rowe Price Investment Management, Inc.
Shares: 14,312,368 · Class: 9.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-26-000700
- Form type
- SCHEDULE 13G/A
- Filer
- T. Rowe Price Investment Management, Inc.
- CIK
- CIK 1897612
- Filed
- Nov 06, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership